Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

ClinicalTrials.gov ID: NCT07013474

Public ClinicalTrials.gov record NCT07013474. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 6, 2026, 8:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, RANDOMIZED, DOUBLE-BLIND, 3-ARM STUDY TO INVESTIGATE IBUZATRELVIR IN ADULTS WITH SYMPTOMATIC COVID-19 WHO ARE SEVERELY IMMUNOCOMPROMISED

Study identification

NCT ID
NCT07013474
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • ibuzatrelvir Drug
  • placebo for ibuzatrelvir Drug
  • placebo for remdesivir Drug
  • remdesivir Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 13, 2025
Primary completion
Dec 5, 2026
Completion
May 5, 2027
Last update posted
May 4, 2026

2025 – 2027

United States locations

U.S. sites
27
U.S. states
11
U.S. cities
14
Facility City State ZIP Site status
UC Davis CTSC Clinical Research Center Sacramento California 95817 Recruiting
University of California Davis Health Sacramento California 95817 Recruiting
UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus Aurora Colorado 80045 Recruiting
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 Recruiting
University of Colorado Hospital Aurora Colorado 80045 Recruiting
D&H Cancer Research Center LLC Margate Florida 33063 Recruiting
Velocity Clinical Research, Savannah Savannah Georgia 31406 Recruiting
Northwestern Memorial Hospital Chicago Illinois 60611 Recruiting
Northwestern University Feinberg School of Medicine Chicago Illinois 60611 Recruiting
Brigham and Women's Hospital Boston Massachusetts 02115 Recruiting
Clinical Trials Center Boston Massachusetts 02115 Recruiting
Clinical Trials Hub Boston Massachusetts 02115 Recruiting
Skylight Health Research, - Burlington Burlington Massachusetts 01803 Recruiting
University of Massachusetts Chan Medical School Worcester Massachusetts 01655 Recruiting
Revive Research Institute, Inc. Farmington Hills Michigan 48334 Recruiting
University of Cincinnati Medical Center Cincinnati Ohio 45219 Recruiting
TRC Pittsburgh Pennsylvania 15213 Not yet recruiting
UPMC Division of Infectious Disease Clinic Pittsburgh Pennsylvania 15213 Not yet recruiting
UPMC Presbyterian IDS Pittsburgh Pennsylvania 15213 Not yet recruiting
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 Not yet recruiting
UPMC Shadyside IDS Pittsburgh Pennsylvania 15232 Not yet recruiting
Baylor University Medical Center Dallas Texas 75246 Not yet recruiting
Houston Methodist Hospital Houston Texas 77030 Recruiting
Memorial Hermann Hospital Houston Texas 77030 Recruiting
The University of Texas Health Science Center at Houston Houston Texas 77030 Recruiting
Swedish Ambulatory Infusion Center- First Hill Seattle Washington 98104 Recruiting
Swedish Cancer Institute Treatment Center Seattle Washington 98104 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07013474, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07013474 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →